Apollo Therapeutics Ltd

This early-phase study tests a new vaccine (APL-10456) designed to protect against rhinovirus, the main cause of the common cold. About 144 healthy volunteers, split into younger (18-54) and older (55+) groups, will receive either the vaccine or a placebo. Researchers will monito…

This study tests a new drug, APL-5125, in about 100 adults with advanced solid tumors like colorectal, pancreatic, and breast cancer that have stopped responding to standard treatments. The goal is to see if the drug is safe and can shrink or control tumors. The trial has two pha…

This study tests an experimental drug called APL-9796, given as injections under the skin, for people with pulmonary hypertension (high blood pressure in the lungs). The goal is to see if it is safe and tolerable, and whether it can improve blood flow and exercise ability. The tr…

This early-stage study tests an experimental drug called APL-4098, alone or with standard chemotherapy drugs, in about 100 adults with acute myeloid leukemia (AML) or related blood cancers that have come back or not responded to treatment. The main goals are to check safety, find…

This study tests a new medicine called camoteskimab for adults with moderate-to-severe atopic dermatitis (eczema). About 280 people will receive either the drug or a placebo to see if it reduces skin redness, swelling, and itching. The main goal is to measure improvement in eczem…